1. Home
  2. GNPX vs MTEK Comparison

GNPX vs MTEK Comparison

Compare GNPX & MTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$0.86

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

Logo Maris-Tech Ltd.

MTEK

Maris-Tech Ltd.

HOLD

Current Price

$1.21

Market Cap

11.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
MTEK
Founded
2009
2008
Country
United States
Israel
Employees
N/A
14
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
11.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
GNPX
MTEK
Price
$0.86
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
732.3K
108.8K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$1.03
52 Week High
$12.97
$4.27

Technical Indicators

Market Signals
Indicator
GNPX
MTEK
Relative Strength Index (RSI) 20.65 37.92
Support Level $0.15 $1.08
Resistance Level $2.12 $1.50
Average True Range (ATR) 0.11 0.12
MACD -0.01 -0.02
Stochastic Oscillator 1.25 5.54

Price Performance

Historical Comparison
GNPX
MTEK

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

Share on Social Networks: